Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease - Nobukatsu Sawamoto; Daisuke Doi; Etsuro Nakanishi; Masanori Sawamura; Takayuki Kikuchi; Hodaka Yamakado; Yosuke Taruno; Atsushi Shima; Yasutaka Fushimi; Tomohisa Okada; Tetsuhiro Kikuchi; Asuka Morizane; et al. (Nature, 2025)